Microbiopsy Market Size, Share, and Industry Analysis, By Product Type (Forceps, Needles, and Others), By Application (Cancer, Actinic Keratosis, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Microbiopsy is a minimally invasive technique that allows clinicians to rapidly collect tiny skin samples, typically less than 0.5mm in diameter, without local anesthesia or sutures. The microbiopsy device is fabricated using laser-cut medical-grade stainless steel. It is designed to extract a sample containing the full thickness of the skin, including the stratum corneum, viable epidermis, dermal-epidermal junction, and superficial dermis. Microbiopsy enables clinicians to analyze the molecular profile of skin conditions, facilitating improved diagnostics and personalized treatments.

The microbiopsy market growth is primarily attributed to the rising incidence of conditions such as cancer and dermatological disorders such as actinic keratosis. These conditions are fueling the demand for microbiopsy devices for early diagnosis, monitoring, and personalized treatment, which is anticipated to boost the market growth during the forecast period.

• For instance, according to Almirall, S.A., in May 2024, actinic keratosis accounts for an estimated prevalence of 13.3% and is one of the most commonly diagnosed diseases among the European population.

In addition, the high incidence of such diseases is further stimulating the prominent players to develop more advanced and precise microbiopsy devices with improved accuracy, minimal tissue damage, and reduced patient discomfort. This is expected to fuel their adoption, driving the market growth in the forthcoming years. Furthermore, the minimally invasive nature of microbiopsy, which leaves behind a tiny puncture site that heals quickly, is preferred over conventionally larger biopsies that require anesthesia and sutures. This is making microbiopsy more appealing for patients and clinicians, and it is projected to surge the market growth in the coming years.

The COVID-19 pandemic had a negative impact on the microbiopsy market in 2020. The pandemic led to delayed skin cancer diagnosis due to the reductions in the number of medical visits for non-urgent procedures. Such a factor decreased the microbiopsy testing rate during the pandemic, thereby decreasing market growth in 2020. However, the delayed diagnosis was carried out more frequently after the first year of the pandemic, which led the market to fall back to its pre-pandemic level.

Segmentation

Key Insights

The report covers the following key insights:

• Incidence of Key Diseases, by Key Countries/Region, 2023
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Overview: Technology Advances in Microbiopsy Tools
• Impact of COVID-19 on the Market  

Analysis by Product Type

Based on the product type, the market is classified into forceps, needles, and others. The forceps segment is projected to account for a significant share of the global microbiopsy market during the forecast period. The growth of this segment is attributed to a high preference for forceps over needles, such as improved tissue sampling, enhanced visibility and control, and better patient tolerance. These benefits associated with the forceps are expected to drive their adoption during the forecast period.

• For instance, as of July 2024, the Moray micro forceps are designed to retrieve cystic lesion tissue from the pancreatic wall reliably.

On the other hand, the needles segment is anticipated to grow at a substantial CAGR during the forecast period. The needles for microbiopsy offer significant advantages in terms of patient comfort, the ability to obtain multiple samples, and sufficient tissue yield for analysis. These factors are driving their adoption of minimally invasive tissue sampling in research and clinical applications, which is anticipated to boost segmental growth in the forthcoming years.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the microbiopsy market during the forecast period. The market growth is primarily attributed to the region's rising incidence of skin cancer. The rising cases of skin cancer are driving the demand for microbiopsy for diagnosis due to its non-invasiveness. Moreover, the existence of major players focused on ensuring product availability in the region is also leading to the high preference for microbiopsy devices. This is expected to boost the regional market growth in the forthcoming years.

• For instance, as of July 2024, the American Academy of Dermatology Association reported that around 9,500 individuals in the U.S. are diagnosed with skin cancer daily.

Asia Pacific is projected to grow significantly during the forecast timeframe. The region's growth is mainly attributed to the increasing focus of key players on research and development in microbiopsy, leading to further advancements and expansion of its applications across various medical domains. This is expected to boost the adoption of microbiopsy devices, propelling the regional market growth during the forecast timeframe.

Key Players Covered

The market consists of significant players such as Leica Biosystems, Nussloch GmbH, Trajan Scientific and Medical, STERIS, MICRO-TECH (Nanjing) Co., Ltd., and BD.

Key Industry Developments

• In December 2022, scientists at the University of Texas at Austin and the University of California Irvine developed a revolutionary laser-based approach to perform microbiopsies. This novel laser microbiopsy system served as a fast and minimally invasive approach for the extraction of tissue samples.
• In October 2022, a researcher from the University of Texas at Austin presented a webinar at the BioPhotonics Conference on laser microbiopsy’s role in providing detailed pathological data with limited sample damage.
• In April 2022, Trajan Scientific and Medical entered into a strategic partnership with researchers at the University of Queensland (UQ) to develop a portable skin microbiopsy device that takes tissue samples smaller than 0.5mm in diameter. The device was designed to collect biopsies for skin conditions, including skin cancers.